Hospital Freiburg大学分子生物学博士后

Head of the CCI T-Cell Platform : Freiburg Germany

Employers:
 
University Hospital Freiburg 

Location(s):

Freiburg Germany

Posted:

September 15, 2010

Expires:

December 01, 2010

Website:

http://www.uniklinik-freiburg.de/cci/live/index.html

Job Tag(s):

molecular biology,cell biology,maxplanckinstitute university,hospital,immunology,t cell

Description:

A postdoctoral position is available in the Centre of Chronic Immunodeficiency (CCI) at the University Medical Center Freiburg (http://www.cci.uniklinik-freiburg.de). The CCI is an integrated research and treatment centre that brings together basic scientists and clinicians interested in understanding immunodeficiency diseases and their treatment. One focus of the CCI is the study of known and identification of novel genetic defects of T-cell immunity. In close collaboration with clinicial immunologists, the CCI advanced diagnostic unit and the CCI research groups, the postdoc should develop and establish a platform for functional screening of human T-cells of immunodeficient patients. Technical support and funds for one technician plus consumables will be provided; applicants are encouraged to obtain outside funding.

The group will have access to cell sorting, imaging and sequencing facilities. The group will be affiliated to the Department of Molecular Immunology, Faculty of Biology, University Freiburg and the Max Planck Institute for Immunobiology that has a long-standing interest in the activation of T lymphocytes. (http://www.immunbio.mpg.de/home/research/molimmun/schamel/index.html).

Applicants should have completed an internationally recognized PhD in Immunology. The group leader position can be filled as soon as possible and the initial appointment will be until October 2013 with an option for a 5-year extension. Payment and social benefits will be in accordance with the regulations of the German TVoeD (salary agreement for public service employees).

Applicants should send their CV, list of publications and a brief statement of research interests and the names/addresses of 3 referees to:

Stephan Ehl, Scientific Director, Centre of Chronic Immunodeficiency, Breisacher Str. 117, 79106 Freiburg,

The University aims to increase the percentage of women in research and teaching, and therefore encourages female candidates meeting the above qualifications to apply. Handicapped candidates with equivalent qualifications will be given preference.

Contact:

Informal inquiries should be directed to Wolfgang Schamel (schamel@immunbio.mpg.de) or Stephan Ehl (stephan.ehl@uniklinik-freiburg.de. Applications will be accepted until 01.12.2010.